Dr. Devendra Mehta, MD
Claim this profileOrlando Health
Studies Congenital Sucrase-Isomaltase Deficiency
Studies Sucrose-Isomaltase Deficiency
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Devendra Mehta, MD is currently running
Megestrol
for Feeding Disorders in Children
This is a multi-center, randomized, placebo-controlled, double-blind clinical trial. The primary focus of the study is the evaluation of the effectiveness of treatment with megestrol as part of a 24 week behavioral feeding protocol in transitioning from tube to oral feedings in a pediatric population. Approximately 60 pediatric subjects matching the criteria for eligibility will be enrolled in the study and randomized to receive either megestrol (n=30) or placebo (n=30).
Recruiting2 awards Phase 46 criteria
Sucraid
for Congenital Sucrase-Isomaltase Deficiency
This trial tests Sucraid®, a medication that helps break down sugars, in children with digestive issues due to low sucrase levels. It aims to see if Sucraid® can reduce symptoms like diarrhea and stomach pain by providing the enzyme needed to digest sugar.
Recruiting3 awards Phase 49 criteria
More about Devendra Mehta, MD
Clinical Trial Related5 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Devendra Mehta, MD has experience with
- Sucraid
- IKanEat Behavioral Intervention
- Megestrol Acetate
Breakdown of trials Devendra Mehta, MD has run
Congenital Sucrase-Isomaltase Deficiency
Sucrose-Isomaltase Deficiency
Inborn Errors of Carbohydrate Metabolism
Feeding Disorders
Eating Disorders
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Devendra Mehta, MD specialize in?
Devendra Mehta, MD focuses on Congenital Sucrase-Isomaltase Deficiency and Sucrose-Isomaltase Deficiency. In particular, much of their work with Congenital Sucrase-Isomaltase Deficiency has involved treating patients, or patients who are undergoing treatment.
Is Devendra Mehta, MD currently recruiting for clinical trials?
Yes, Devendra Mehta, MD is currently recruiting for 2 clinical trials in Orlando Florida. If you're interested in participating, you should apply.
Are there any treatments that Devendra Mehta, MD has studied deeply?
Yes, Devendra Mehta, MD has studied treatments such as Sucraid, iKanEat Behavioral Intervention, Megestrol Acetate.
What is the best way to schedule an appointment with Devendra Mehta, MD?
Apply for one of the trials that Devendra Mehta, MD is conducting.
What is the office address of Devendra Mehta, MD?
The office of Devendra Mehta, MD is located at: Orlando Health, Orlando, Florida 32806 United States. This is the address for their practice at the Orlando Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.